All News #Library
Rare Diseases
FDA Accepts Vanda`s BLA for Imsidolimab in GPP Psoriasis
25 Feb 2026 //
PR NEWSWIRE
Vanda Gets FDA ODD Designation for VGT-1849B in Polycythemia Vera
28 Aug 2025 //
PR NEWSWIRE
Vanda Pharmaceuticals: First Patient Dosed in VCA-894A Trial
10 Jun 2025 //
PR NEWSWIRE
Vanda Pharma Announces Orphan Drug Designation for VGT-1849A
20 Dec 2024 //
PR NEWSWIRE
Vanda gets $466M takeout bid from Cycle Pharma
06 Jun 2024 //
FIERCE PHARMA

Market Place
Sourcing Support